Trade Pfizer ^PFE

Pharma Stock Roundup: NVO's Obesity Study Failure, FDA Nod to PFE, LLY - December 26, 2024 - Zacks.com

Pfizer (NYSE:PFE) Stock Price Up 0.1% - Here's Why

Is Pfizer Inc. (PFE) the Best Dividend Stock to Buy Under $50?

Pfizer (NYSE:PFE) Shares Down 0.2% - Time to Sell?

Pfizer (NYSE:PFE) Stock Price Down 0% - What's Next?

Javed Mirza's Top Picks: Tamarack Valley Energy, Peyto Exploration & Development and Pfizer - BNN Bloomberg

Pfizer Gets Enanta Patent Voided in Case Over Paxlovid Royalties

Enanta Pharmaceuticals to Appeal Ruling in Patent Infringement Case Against Pfizer | Morningstar

Enanta Plans To Appeal Court Ruling Related To 953 Patent Infringement Lawsuit

Pfizer prevails in Enanta patent case over Covid-19 drug By Investing.com

Enanta Pharma to Appeal Ruling Related to '953 Patent Infringement Lawsuit By Investing.com

FDA Grants Accelerated Approval to Pfizer’s Braftovi Combination for Metastatic Colorectal Cancer

Pfizer (NYSE:PFE) Trading Down 0.2% - Here's What Happened

FY2025 EPS Estimates for Pfizer Increased by Leerink Partnrs

TD Cowen Sticks to Its Hold Rating for Pfizer (PFE)

Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? - December 23, 2024 - Zacks.com

Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years?

Pfizer (NYSE:PFE) Trading Up 0.4% – Time to Buy?

FDA Grants Accelerated Approval To Pfizer's BRAFTOVI Combination For Metastatic Colorectal Cancer

Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children

Pfizer Gains FDA Approval for Colorectal-Cancer Treatment | Morningstar

Pfizer (NYSE:PFE) Trading Up 1.6% - What's Next?

Principal Financial Group Inc. Sells 1,349,308 Shares of Pfizer Inc. (NYSE:PFE)

Applied Therapeutics CEO Steps Down, Les Funtleyder Appointed As Interim CEO | Markets Insider

Is Pfizer (PFE) a Cheap NYSE Stock to Invest in Now?

Leerink Partnrs Estimates Pfizer's Q3 Earnings (NYSE:PFE)

Principal Financial Group Inc. Decreases Stake in Pfizer Inc. (NYSE:PFE)

The Biggest CMO Moves of 2024

FDA approves new first-line treatment for BRAF V600E mCRC By Investing.com

Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS)

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals - December 20, 2024 - Zacks.com

Aadi Bioscience adds Baiteng Zhao to board

Pfizer (NYSE:PFE) Trading 0.4% Higher - Time to Buy?

Pfizer Inc (PFE) Announces Upcoming Webcast for Fourth Quarter and Full Year 2024 Performance Report

Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts | Morningstar

Pfizer (NYSE:PFE) Issues FY25 Earnings Guidance

Local Anesthesia Drugs Market Drivers: Technological Advances Transforming Pain Relief Options – Express Press Release Distribution

Pfizer's SWOT analysis: stock outlook amid pipeline progress and cost cuts By Investing.com

Jim Cramer’s Take on Pfizer (PFE): Can CEO Dr. Bourla’s Bold Strategy Overcome Debt and Turn the Stock Around?

IMS Capital Management Has $3.02 Million Stock Position in Pfizer Inc. (NYSE:PFE)

Truist Financial Issues Pessimistic Forecast for Pfizer (NYSE:PFE) Stock Price

Pfizer (NYSE:PFE) Trading Up 0.5% – What’s Next?

Truist cuts Pfizer shares target, retains buy rating on growth projections By Investing.com

Pfizer reiterated at Market Perform by analyst following FY25 guidance By Investing.com

Pfizer (NYSE:PFE) Issues FY 2024 Earnings Guidance

Syntax Research Inc. Reduces Position in Pfizer Inc. (NYSE:PFE)

Novavax is as protective as other Covid vaccines, but has fewer side effects | Vox

Pfizer (NYSE:PFE) Updates FY 2025 Earnings Guidance

Arvinas's SWOT analysis: biotech firm's stock faces pivotal trial results By Investing.com

BlinkLab Limited (ASX: BB1) – Trading Halt

Cautious Hold Rating for Pfizer Amidst Stable Near-Term Outlook and Long-Term Concerns

Pfizer’s Balanced Outlook: Hold Rating Amid Uncertainties and Growth Potential

Pfizer’s Stable Outlook Amid Growth Challenges and Policy Risks Leads to Hold Rating

Stocks To Watch: NHPC, Reliance Power, Ambuja Cements, Exide Industries, REC, Jindal Saw, Pfizer, Granules India

News Highlights: Top Company News of the Day - Tuesday at 5 PM ET | Morningstar

Pfizer (NYSE:PFE) Trading Up 4% - Here's What Happened

News Highlights: Top Company News of the Day - Tuesday at 3 PM ET | Morningstar

News Highlights: Top Company News of the Day - Tuesday at 1 PM ET | Morningstar

Pfizer (NYSE:PFE) Shares Gap Up – Still a Buy?

Pfizer (NYSE:PFE) Shares Gap Up - Still a Buy?

Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030

Pfizer On Pace for Largest Percent Increase Since May — Data Talk | Morningstar

HEALTHCARE: Pfizer (PFE: A2/A): 2025 Guidance

Pfizer Signals Growth in FY 2025 Guidance, Projects Revenue Up to $64 Billion

Pfizer (NYSE:PFE) Issues FY24 Earnings Guidance

Pfizer (NYSE:PFE) Updates FY25 Earnings Guidance

Stocks making the biggest moves premarket: PFE, TSLA, SEDG, RCAT and more

Pfizer Sees 2025 Revenue in Line With Wall Street Views — Update | Morningstar

In relief for investors, Pfizer 2025 profit forecast in line with estimates | Company News - Business Standard

Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise By Investing.com

Pfizer (NYSE:PFE) Releases FY 2025 Earnings Guidance

Pfizer Sees 2025 Revenue in Line With Wall Street Views, Despite Hit from Benefit Changes | Morningstar

Pfizer’s In-Line Guidance Offers Relief to Weary Investors

Is Pfizer Inc. (PFE) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround

Pfizer Expects 2025 Adj. EPS Operational Growth Of 10% To 18%; Reaffirms 2024 Guidance

US health-care stocks dip on Trump's commitment to PBM reform By Investing.com

10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

Pfizer projects 2025 earnings to align with expectations By Investing.com

Lava Therapeutics' SWOT analysis: stock faces challenges after key asset discontinuation By Investing.com

Wall Street today: US stocks slip after strong retail sales data, Nvidia dips 3.5%, Pfizer jumps 4%

Pfizer CEO: Trump 'Very Proud' Of COVID Vaccine 12/18/2024

Wall Street: US stocks slip after strong retail sales data, Nvidia dips 3.5%, Pfizer jumps 4% - Why markets are falling

Symbol: PFE Security name: Pfizer CDR (CAD Hedged) Status:

Pfizer (NYSE:PFE) Trading Up 0.5% - Here's Why

Arbutus Biopharma's SWOT analysis: hepatitis B focus drives stock potential By Investing.com

Pfizer (PFE) Gets a Hold from Wells Fargo | Markets Insider

Pfizer's SWOT analysis: stock outlook amid pipeline progress and market challenges By Investing.com

Sangamo Therapeutics' SWOT analysis: gene therapy firm's stock faces hurdles By Investing.com

Beaird Harris Wealth Management LLC Reduces Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer (PFE) Is Too Cheap To Ignore

Pfizer Inc. (NYSE:PFE) Position Trimmed by B. Riley Wealth Advisors Inc.

Franklin Resources Inc. Has $477.76 Million Position in Pfizer Inc. (NYSE:PFE)

Tidal Investments LLC Grows Holdings in Pfizer Inc. (NYSE:PFE)

Asian stock market today: most Asian stocks rise amid thin holiday trading

Stock market today: Nasdaq, S&P 500, Dow surge ahead of Christmas break

SPOT stock price: Spotify stock reaches all-time highs

DRCT stock price today: Direct Digital Holdings spikes on high-volume move

Stock Market Today: Dow Jones Closes Higher for Third Consecutive Day

Morning Note: GDP in the UK, Spain and Canada to Shake Markets Today

Bitcoin ETFs Experience Record Outflows Amid Crypto Market Decline

Analyst revises Amazon stock forecast following major 'moonshot' initiative